Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
Oxford Pharmascience Group Plc
Oxford Pharmascience Group Plc
Activities:
Drug Delivery
Research & Development
Pharmaceutical
Patient Experience
X
LinkedIn
Trending Articles
From subscriptions to mushrooms: BCMPA members discuss the latest outsourcing trends in nutraceuticals
From single-serve sachets catering to the busy on-the-go market to specialised subscription models shaping direct-to-consumer interactions, the nutraceutical industry is...
The perfect pair: how vitamins K2 and D3 combine to support health and well-being
Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
LifeinU BSCU1: embrace your health now and for the future
New biotics solutions are flooding the market to capitalise on the ever-changing immunity seeking consumer. However, one probiotic solution, LifeinU® BSCU1 from Gnosis by...
Macalat earns NEXTY award for chocolate mushroom mycelium technology
The organic brand has created a novel category in the chocolate industry: sweet dark chocolate
Mibelle Biochemistry has strengthened its beauty-from-within portfolio
PhytoCellTec Md Nu, a novel anti-aging solution, utilises the power of apple fruit cell culture extract to boost skin stem cell vitality and enhance skin density, elasticity,...
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Ingredients
Ellactiva adds two chews to Boost immunity range
Like the company’s Collagen& soft chews, the Boost range does not include added sugars
Ingredients
Beyond skin deep benefit from Ellactiva
Lat week, Oxford Pharmascience used Vita Foods Europe as the launch platform for its new and holistic range of sugar free, Ellactiva branded Collagen& soft chews
Subscribe now